<FONT SIZE = "150"
Only 2.5 percent of Spanish children suffering from diabetes have insulin bomb, unlike countries such as Holland, where the percentage reaches 25 percent, Roche reported today in a statement, on the occasion of the presentation of aBook on the use of this tool, which has taken place within the framework of the XXXI Congress of the Spanish Society of Pediatric Endocrinology.
The head of the Pediatric Diabetes Unit of the Pediatrics Service of the Ramón y Cajal University Hospital, Dr. Raquel Barrio, said that "the objective of this publication has been to translate the experience with these treatments, which have proven to be a good therapeutic option forchildren with lower ages even at age five. "
In this regard, the doctor pointed out that recent reports such as the Berghaeuser study, carried out in Germany and Austria with 104 patients, demonstrated that the use of insulin pump offers results similar to multiple dose therapy, but a lower risk ofHypoglycemia.
For its part, the director of the Diabetes Unit of the San Joan de Dèu Hospital (Barcelona), Dr. Marisa Torres, highlighted the need to create a central registration of insulin pumps in which to commonly put the data of each center, and said that since 2005 the use of this therapy has been duplicated due to access to public financing."We played with disadvantage against other countries, where full financing was enjoyed for years," he added.
As experts explained, the main advantages offered by infusor against the usual treatment with multiple doses of insulin are, mainly, the flexibility that allows treatment, since the dose can be individualized to the maximum.It also produces a reduction in the number of punctures necessary and, as demonstrated by numerous publications, improves glycemic control with a reduction in the number of hypoglycemia.
